CRVO
CervoMed·NASDAQ
--
--(--)
--
--(--)
8.94 / 10
Outperform
Analyst consensus is overwhelmingly bullish: six Strong Buy ratings (100%). Fund‑flow score is 7.81 (good) with overall positive inflows, though medium and large investors show slight outflows. Sentiment rating is Outperform, suggesting strong capital support despite mixed historical analyst performance.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Boobalan PachaiyappanStrong Buy
Date2026-03-18
InstitutionRoth Capital
Times predicted2
Historical Win Rate50.0%
Daniil GataulinStrong Buy
Jason KolbertStrong Buy
What is the market sentiment for CRVO?
- CRVO holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.94/10 (Outperform).
